It has been shown that MMP3 and CCN2 (aka connective tissue growth factor (CTGF)) are often increased in tumor–stroma tissues or patients’ serum, and are thus biomarkers correlated with poor prognosis in cancer [18,19,20,21,22]. The gene discussed is MMP3; the disease is neoplasm.